Unconventional T Cell Targets for Cancer Immunotherapy

Slides:



Advertisements
Similar presentations
Structure of a Ubiquitin E1-E2 Complex: Insights to E1-E2 Thioester Transfer Shaun K. Olsen, Christopher D. Lima Molecular Cell Volume 49, Issue 5, Pages.
Advertisements

Bacterial Entry to the Splenic White Pulp Initiates Antigen Presentation to CD8+ T Cells Taiki Aoshi, Bernd H. Zinselmeyer, Vjollca Konjufca, Jennifer.
Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni
The Transcription Factor Foxo1 Controls Central-Memory CD8+ T Cell Responses to Infection Myoungjoo V. Kim, Weiming Ouyang, Will Liao, Michael Q. Zhang,
Lung Natural Helper Cells Are a Critical Source of Th2 Cell-Type Cytokines in Protease Allergen-Induced Airway Inflammation Timotheus Y.F. Halim, Ramona.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
Lung Airway-Surveilling CXCR3hi Memory CD8+ T Cells Are Critical for Protection against Influenza A Virus Bram Slütter, Lecia L. Pewe, Susan M. Kaech,
Germline Energetics, Aging, and Female Infertility Jonathan L. Tilly, David A. Sinclair Cell Metabolism Volume 17, Issue 6, Pages (June 2013) DOI:
Cell-to-Cell Transfer of M. tuberculosis Antigens Optimizes CD4 T Cell Priming Smita Srivastava, Joel D. Ernst Cell Host & Microbe Volume 15, Issue 6,
Gastrulation Movements: the Logic and the Nuts and Bolts Maria Leptin Developmental Cell Volume 8, Issue 3, Pages (March 2005) DOI: /j.devcel
Small but Mighty: Selected Commensal Bacterial Species Determine the Effectiveness of Anti-cancer Immunotherapies  Jose R. Conejo-Garcia, Melanie R. Rutkowski 
Antigen-Primed CD8+ T Cells Call DCs for Back Up
Human-Hemato-Lymphoid-System Mice: Opportunities and Challenges
Cancer Immunosurveillance Caught in the Act
Immunoengineering: How Nanotechnology Can Enhance Cancer Immunotherapy
Volume 34, Issue 3, Pages (March 2011)
Volume 44, Issue 1, Pages (January 2016)
CD5: A New Partner for IL-6
Why Is There so Much CD45 on T Cells?
Vaccine Adjuvants: Putting Innate Immunity to Work
Volume 29, Issue 5, Pages (November 2008)
Some DCs Are “B”etter Immunity
It Takes Two to Tango Immunity
Tumor Evolution: A Problem of Histocompatibility
Chronic Infections Capture Little Attention of the Masses
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
Mammary Tumorigenesis through LPA Receptor Signaling
T Helper 17 Cells Get the NOD
Juan Rivera, Lino Tessarollo  Immunity 
Mitchell Kronenberg, Yuki Kinjo  Immunity 
Comparison of ternary TCR-lipid-CD1 complex structures.
Thymic Selection: To Thine Own Self Be True
Shannon M. Kahan, Allan J. Zajac  Immunity 
Getting the Skinny on CD4+ T Cell Survival in Fatty Livers
Anette H.H. van Boxel-Dezaire, M.R. Sandhya Rani, George R. Stark 
Chronic Infections Capture Little Attention of the Masses
E Proteins Enforce Security Checkpoints in the Thymus
Volume 35, Issue 4, Pages (October 2011)
In Vivo Role of pDCs in Regulating Adaptive Immunity
Maria A. Curotto de Lafaille, Juan J. Lafaille  Immunity 
Wait, Wait … OK Now Go In: iNKT Cells Resolve Liver Inflammation
Volume 31, Issue 1, Pages (July 2009)
Late Arrival: Recruiting Coreceptors to the T Cell Receptor Complex
Volume 31, Issue 1, Pages (July 2009)
Immunological Synapse: Center of Attention Again
Andrew Johnston, Johann E. Gudjonsson 
A Molecular Basis for NKT Cell Recognition of CD1d-Self-Antigen
The TCR Takes Some Immune Responsibility
Volume 37, Issue 4, Pages (October 2012)
HIV and HLA Class I: An Evolving Relationship
Robbie G. Majzner, Sabine Heitzeneder, Crystal L. Mackall  Cancer Cell 
Volume 30, Issue 2, Pages (February 2009)
One Bug or Another: Promiscuous T Cells Form Lifelong Memory
Comparison of ternary TCR-lipid-CD1 complex structures.
A New Angle on TCR Activation
Releasing the Brakes on Cancer Immunotherapy
Taking a Toll Road to Better Vaccines
Licensing PPARγ to Work in Macrophages
t Testing the Immune System
Some DCs Are “B”etter Immunity
Volume 25, Issue 5, Pages e8 (May 2018)
Nora A. Barrett, K. Frank Austen  Immunity 
Notch 1 Keeps Pro-T cells on Track
Marking Emerging β- and γδ-Selected T Cells
A “Big Data” View of the Tumor “Immunome”
André Veillette, Zhongjun Dong, Sylvain Latour  Immunity 
Stable IL-10: A New Therapeutic that Promotes Tumor Immunity
Of Human DC Migrants and Residents
Presentation transcript:

Unconventional T Cell Targets for Cancer Immunotherapy Dale I. Godfrey, Jérôme Le Nours, Daniel M. Andrews, Adam P. Uldrich, Jamie Rossjohn  Immunity  Volume 48, Issue 3, Pages 453-473 (March 2018) DOI: 10.1016/j.immuni.2018.03.009 Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 1 Unconventional T Cell Types Unconventional T cells, divided into groups based on their restriction elements. 5-OP-RU, 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil; 6-FP, 6-formylpterin; Ag, antigen; a-GalCer, a-galactosylceramide; DDM, dideoxymycobactin; GEM, germline-encoded mycolyl lipid-reactive; GMM, glucose monomycolate; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; mLPA, methyl lysophosphatidic acid; MAIT, mucosal-associated invariant T; NKT, natural killer T; PG, phosphatidylglycerol; PM, phosphomycoketide; ? = insufficient or very limited data; 1, H2-M3 and Qa-2 restricted T cells are mouse only; 2, human TCR sequences shown; 3, only human gd T cells shown. Immunity 2018 48, 453-473DOI: (10.1016/j.immuni.2018.03.009) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 2 CD1-Restricted Lipid-Based Ags (A) shows a cartoon of a type I NKT cell recognizing α-GalCer presented by a CD1d+ Ag presenting cell. The ternary crystal structure of the TCR-CD1d-α-GalCer complex is shown in the inset. (B) shows a sample of synthetic lipid analogs that have the ability to provide enhanced and/or Th1-biased type I NKT cell responses. (C) shows examples of tumor-derived lipid Ags that are capable of being recognized by CD1d-restricted T cells, with the exception of mLPA that is recognized by CD1c-restricted T cells. α-GalCer, α-galactosylceramide; mLPA, methyl lysophosphatidic acid; NKT, natural killer T. Immunity 2018 48, 453-473DOI: (10.1016/j.immuni.2018.03.009) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 3 MR1-Restricted Vitamin B Metabolite Ags (A) shows a cartoon of a MAIT cell recognizing a vitamin B metabolite presented by an MR1+ Ag presenting cell. The ternary crystal structure of the MAIT TCR-MR1-Ag complex is shown in the inset. (B) shows some examples of vitamin-B derivative Ags that have the ability to bind to MR1 and, with varying degrees of potency, to stimulate MAIT cells via their TCR. The exceptions are 6-FP and Acetyl-6-FP (Ac-6-FP) which bind MR1, but are not stimulatory for the majority of MAIT cells. 5-OP-RU, 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil; 6-FP, 6-formylpterin; Ag, antigen; MAIT, mucosal-associated invariant T. Immunity 2018 48, 453-473DOI: (10.1016/j.immuni.2018.03.009) Copyright © 2018 Elsevier Inc. Terms and Conditions